Skip to main content
NEOHealthcare

Neogenomics Inc. (NEO) Insider Trading

In the last 90 days, 1 Neogenomics Inc. (NEO) insider reported no open-market purchases and 1 sale totaling $321,400. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 4, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 4, 2026Greg D AunanChief Accounting OfficerSale20,000$16.07$321,400
Jun 15, 2026Lynn A. TetraultCorporate insiderSale5,307$11.10$58,908
Jun 9, 2026Lynn A. TetraultCorporate insiderSale5,307$11.29$59,916

Common questions

NEO insider trading FAQ

Are NEO insiders buying or selling?
Over the last 90 days, NEO insiders were net sellers, reporting $0.00 of open-market purchases and $321,400 of sales.
When was the last NEO insider purchase?
No open-market insider purchase of Neogenomics Inc. stock was reported in the last 90 days.
Where does NEO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Neogenomics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.